CHOROIDEREMIA

Clinical trials for CHOROIDEREMIA explained in plain language.

Never miss a new study

Get alerted when new CHOROIDEREMIA trials appear

Sign up with your email to follow new studies for CHOROIDEREMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

Gene therapy injection aims to restore sight in rare eye diseases

Disease control Ongoing

This early-phase trial tests a single injection of a gene therapy called RTx-015 in 10 adults with retinitis pigmentosa or choroideremia, two inherited conditions that cause vision loss. The therapy delivers a gene that makes retinal cells produce a light-sensitive protein, poten…

Matched conditions: CHOROIDEREMIA

Phase: PHASE1 • Sponsor: Ray Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:07 UTC

CHOROIDEREMIA

Get alerted when new CHOROIDEREMIA trials appear

Gene therapy injection aims to restore sight in rare eye diseases